金吾财讯 | 再鼎医药（09688）盘中震荡走高，截至发稿，最新报18.51港元，涨幅1.87%，成交额3121.83万港元。消息面上，公司公告披露，2026年第三季度总收入为1.082亿美元，去年同期为1.161亿美元。公司产品收入净额为1.076亿美元，环比增长2%。期内亏损净额为4,610万美元。研发开支为4,980万美元，SG&A开支为7,010万美元，同比均基本持平。展望2027年，公司预计多个全球项目成为催化剂：zoci二线及以上小细胞肺癌全球3期研究DLLEVATE有望2027年下半年中期分析，随后在美国递交加速批准BLA；zoci二线肺外神经内分泌癌数据预计2027年上半年公布，随后递交BLA；ZL-1503预计2027年上半年获得特应性皮炎患者数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.